Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05627180
Other study ID # 341
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 30, 2023
Est. completion date December 31, 2026

Study information

Verified date March 2023
Source Lovisenberg Diakonale Hospital
Contact Christine R Borge, PhD
Phone +47 23225000
Email chrr@lds.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Health literacy refers to personal and relational factors affecting a persons ability to aquire, understand and use health information and health services. In a need assessment study, it was found that there is a need to focus on health literacy factors in the follow-up of people with cancer in the health care services. Thus, this project evaluate the effect of a health literacy intervention in cancer. The intervention provides patients with nurse-led tailored follow-up by phone/digital/personal meetings that addresses their individual HL needs, particularly those needs that impact their quality of life, symptom burden, self-management, and health economic costs. Our main goal is to improve the patients' health literacy, with secondary goals of improving their quality of life, symptom burden, and self-management, and reducing their health care costs.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2026
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosed with cancer - Above 18 years old - Receiving treatment at the main intervention hospital Exclusion Criteria: - Not diagnosed with cancer - Not above 18 years old - Not in treatment at the intervention hospital

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored Health Literacy follow-up in cancer
Participants are invited to a consultation with the project nurse where the project nurse will use baseline data to identify the patient's HL needs, QOL, symptom burden and issues related to self-management of their cancer and treatment. These data will be used together with an interview questionnaire specifically developed to communicate HL needs (i.e. CHAT), which form the basis for the individualized HL support. Actions: Based on results of the consultation, the project nurse and the patient will use a worksheet of possible actions to identify those most relevant to the patient's individual needs. Based on this, different self-management tasks and actions will be offered, and an individual tailored follow-up plan will be made. The patient and the project nurse will use a workbook containing information on the follow-up plan that will be added into medical record. Telephone/digital conversations with the project every second month for a period of 9 months.

Locations

Country Name City State
Norway Lovisenberg Diakonale Hospital Oslo

Sponsors (2)

Lead Sponsor Collaborator
Lovisenberg Diakonale Hospital University of Oslo

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary General Health literacy measured with the Health Literacy Questionnaire (HLQ) Change of Health Literacy questionnaire 6 months, 9 months
Secondary Electronic Health Literacy measured with the electronic Health Literacy Questionnaire (eHLQ) Change of electronic Health Literacy questionnaire 6 months, 9 months
Secondary General symptoms measured with the Edmonton Symptom Assessment System (ESAS) Change of symptom burden questionnaire 6 months, 9 months
Secondary Oral symptoms measured with four items selected from the European Organization for REsearch and Treatment of Cancer-oral health 15 (EORTC-OH 15) Change in oral symptoms 6 months, 9 months
Secondary Self-management measured with the Health Education Impact Questionnaire (HeiQ) Change of self-management questionnaire 6 months, 9 months
Secondary Self-Efficacy measured with the General Self-efficacy Scale (GSE) Change of Self-efficacy questionnaire 6 months, 9 months
Secondary Disease specific Quality of Life measured with the The functional Assessment of Cancer Therapy-General (FACT-G) Change of quality of life questionnaire 6 months, 9 months
Secondary Generic health-related quality of life/quality adjusted life years measured by the EQ-5D Change in health related quality of life and adjusted life years 6 months, 9 months
Secondary Health care costs measured through collecting data from patient medical records, patient self-report, and data registers Change of health care costs 6 months, 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases